Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
Abstract Introduction Studies using different assays and technologies showed highly promising diagnostic value of plasma phosphorylated (P-)tau levels for Alzheimer’s disease (AD). We aimed to compare six P-tau Simoa assays, including three P-tau181 (Eli Lilly, ADx, Quanterix), one P-tau217 (Eli Lil...
Enregistré dans:
Auteurs principaux: | Sherif Bayoumy, Inge M. W. Verberk, Ben den Dulk, Zulaiga Hussainali, Marissa Zwan, Wiesje M. van der Flier, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, Jeroen Vanbrabant, Erik Stoops, Eugeen Vanmechelen, Jeffrey L. Dage, Charlotte E. Teunissen |
---|---|
Format: | article |
Langue: | EN |
Publié: |
BMC
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9a80f98ef3db432c84a8599a0bf54390 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
To target Tau pathologies, we must embrace and reconstruct their complexities
par: Galina Limorenko, et autres
Publié: (2021) -
Simple, Single-Shot Phosphoproteomic Analysis of Heat-Stable Tau Identifies Age-Related Changes in pS235- and pS396-Tau Levels in Non-human Primates
par: Shannon N. Leslie, et autres
Publié: (2021) -
Clioquinol Decreases Levels of Phosphorylated, Truncated, and Oligomerized Tau Protein
par: Gaoping Lin, et autres
Publié: (2021) -
A Computational Model of the Trans-Synaptic Spread of Pathogenic Tau in Early Alzheimer’s Disease
par: Bashir Sbaiti, et autres
Publié: (2021) -
Differential Effects of Human P301L Tau Expression in Young versus Aged Mice
par: Holly C. Hunsberger, et autres
Publié: (2021)